 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|
||||||||||||||||
| ||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thanks to Internet Technology you can now have access to affordable Evista without leaving the comfort of your home. A prior permission is NOT required but we do recommend you consult a physician before place Evista ordering. Order Evista drugs on Sale. Q. What countries do you Evista ship to? A. RxBrandMeds.net ships Evista to all countries. Q. Will my drugs be shipped in a discreet package? A. Yes! All goods, including Evista, are packaged discreetly. The Evista cannot be identified from the packaging. We do not include company logo's etc on the outside of the package. Q. Are USA, Canada, UK and Europe within your shipping range? A. Yes. We can ship Evista anywhere in the world. Q. When shall I receive my Evista order? A. We will ship Evista within 24 hours. Shipping using regular airmail takes between 7-14 days worldwide. Q. What is a brand name drug Evista? A. A brand name drug Evista is approved by the Food and Drug Administration (FDA), and is supplied by one company (the pharmaceutical manufacturer). The drug is protected by a patent and is marketed under the manufacturer's brand name. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
.Raloxifene is prescribed for the prevention and treatment of osteoporosis in post-menopausal women. Estrogen is a hormone which among other actions, regulates the turnover (formation and destruction) of bone. Decreases in estrogen levels that are seen after menopause or after removal of the ovaries, lead to a loss of bone density and weakened bones, a condition called osteoporosis. Raloxifene decreases bone turnover and increases bone density although not to the same extent as estrogen itself. This makes bones stronger and prevents fractures in women with osteoporosis. Raloxifene is called a 'selective estrogen receptor modulator' since it has effects like estrogen on some tissues but inhibits the effects of estrogen on other tissues. Raloxifene decreases low density lipoprotein (LDL or 'bad') cholesterol in the blood; however, unlike estrogen, raloxifene does not increase high density lipoprotein (HDL or 'good') cholesterol. . . Used to prevent and treat osteoporosis, a disease common in women past menopause, which results in bones that break easily Evista is a newly approved drug used for the prevention of osteoporosis in post-menopausal women. It is classified as a Selective Estrogen Receptor Modulator (SERM). This means that it produces its effects by binding to estrogen receptors thereby inducing an estrogen-like response in certain parts of the body. Evista has been shown to reduce the body's resorption of bone, and thus decrease the overall bone turnover. In addition, Evista has been shown to decrease total cholesterol and LDL cholesterol, otherwise known as "bad" cholesterol. No effects have been observed on levels of triglycerides and HDL cholesterol. Used to prevent and treat osteoporosis, a disease common in women past menopause, which results in bones that break easily Raloxifene is used for: Treating and preventing osteoporosis (bone thinning) in women past menopause. Ralista is prescribed to treat and prevent osteoporosis, the brittle-bone disease that strikes some women after menopause. A variety of factors promote osteoporosis. The more factors that apply to you, the greater your chances of developing the disease. These factors include:Caucasian or Asian descentSlender buildEarly menopauseSmokingDrinkingA diet low in calciumAn inactive lifestyleOsteoporosis in the familyRaloxifene affects the cycle of bone formation and breakdown in the body, and reduces loss of bone tissue. Raloxifene is used to treat or prevent osteoporosis in postmenopausal women. Raloxifene is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer. Ralista (Raloxifene hydrochloride) is a selective estrogen receptor modulator (SERM) that belongs to the benzothiophene class of compounds. Raloxifene's biological actions are largely mediated through binding to estrogen receptors. This binding results in activation of certain estrogenic pathways and blockade of others. Thus, raloxifene is a selective estrogen receptor modulator (SERM). |
Copyright © Copyright 2000-2019. RXBrandMeds.net
Products mentioned are trademarks of their respective companies
For medical advice, diagnoses, and treatment, consult your doctor.
Drugs without prescription
Products mentioned are trademarks of their respective companies
For medical advice, diagnoses, and treatment, consult your doctor.
Drugs without prescription